Administration of Recombinant Rhesus Interleukin-12 during Acute Simian Immunodeficiency Virus (SIV) Infection Leads to Decreased Viral Loads Associated with Prolonged Survival in SIVmac251-Infected Rhesus Macaques

The ability of recombinant rhesus interleukin-12 (rMamu-IL-12) administration during acute simian immunodeficiency virus SIVmac251 infection to influence the quality of the antiviral immune responses was assessed in rhesus macaques. Group I (n = 4) was the virus-only control group. Group II and III...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Ansari, A. A., Mayne, A. E., Sundstrom, J. B., Bostik, P., Grimm, B., Altman, J. D., Villinger, F.
Formato: Artigo
Idioma:Inglês
Publicado: American Society for Microbiology 2002
Assuntos:
Pathogenesis and Immunity
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC135900/
https://ncbi.nlm.nih.gov/pubmed/11799168
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.76.4.1731-1743.2002
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares